| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Apr 29, 2024 |
Director
Trans History: 624
|
Director | Form 4 | Other acquisition or disposition | -- | -- | 150,000 |
| Apr 29, 2024 |
Director
Trans History: 24
|
Director | Form 4 | Other acquisition or disposition | -- | -- | 5,000 |
| Apr 26, 2024 |
Director
Trans History: 30
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 181 | -- | 27,925 |
| Apr 26, 2024 |
Director
Trans History: 144
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 227 | -- | 139,254 |
| Apr 26, 2024 |
EVP Chief Risk Officer
Trans History: 47
|
EVP Chief Risk Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 454 | -- | 47,899 |
| Apr 26, 2024 |
Director
Trans History: 212
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 245 | -- | 425,464 |
| Apr 26, 2024 |
Director
Trans History: 43
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 191 | -- | 139,995 |
| Apr 26, 2024 |
Director, President & CEO
Trans History: 641
|
Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 1,896 | -- | 402,816 |
| Apr 26, 2024 |
Director
Trans History: 28
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 180 | -- | 50,891 |
| Apr 26, 2024 |
EVP & CFO
Trans History: 77
|
EVP & CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 782 | -- | 91,388 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.